Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.86 is 92% above its 5-year average of -24.28, near the high end of its 5-year range (-37.35–-1.86).
50.27% above its 12-month average of -3.74.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.43.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:01:03.257Z. Historical observations retain their original dates. Historical series through 2024-02-21.
EARNINGS PER SHARE (EPS)
-1.86
EARNINGS PER SHARE (EPS) AVG TTM
-3.74
EARNINGS PER SHARE (EPS) AVG 3Y
-18.16
EARNINGS PER SHARE (EPS) AVG 5Y
-24.28
EARNINGS PER SHARE (EPS) AVG 10Y
-4758.75
EARNINGS PER SHARE (EPS) AVG 15Y
-1593.49
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.27%
CURRENT VS 3Y AVG
+89.76%
CURRENT VS 5Y AVG
+92.34%
CURRENT VS 10Y AVG
+99.96%
CURRENT VS 15Y AVG
+99.88%
CURRENT VS 20Y AVG
N/A
Bone Biologics Corporation
Market Cap
$873327.00
Earnings Per Share (EPS)
-1.86
TTM Avg
-3.74
3Y Avg
-18.16
5Y Avg
-24.28
Market Cap
$885939.00
Earnings Per Share (EPS)
-180.45
TTM Avg
-617.40
3Y Avg
-559.80
5Y Avg
-483.70
Market Cap
$848489.00
Earnings Per Share (EPS)
-29.09
TTM Avg
-56.46
3Y Avg
-589.82
5Y Avg
-783.52
Market Cap
$825495.00
Earnings Per Share (EPS)
-11.80
TTM Avg
-236.00
3Y Avg
-263.84
5Y Avg
-205.13
Market Cap
$809925.00
Earnings Per Share (EPS)
-233.09
TTM Avg
20691.39
3Y Avg
-239348.05
5Y Avg
-408377.87
Market Cap
$1.03M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
-7.51
Market Cap
$670456.00
Earnings Per Share (EPS)
-5669.00
TTM Avg
-313854.00
3Y Avg
-213259.50
5Y Avg
-170757.60
Market Cap
$1.08M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.10M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
0.05
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bone Biologics Corporation (BBLG) | $873327.00 | -1.86 | -3.74 | -18.16 | -24.28 |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | -180.45 | -617.40 | -559.80 | -483.70 |
| Decoy Therapeutics Inc. (DCOY)vs › | $848489.00 | -29.09 | -56.46 | -589.82 | -783.52 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $825495.00 | -11.80 | -236.00 | -263.84 | -205.13 |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | -233.09 | 20691.39 | -239348.05 | -408377.87 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -8.02 | -25.27 | -9.38 | -7.51 |
| CDT Equity Inc. (CDT)vs › | $670456.00 | -5669.00 | -313854.00 | -213259.50 | -170757.60 |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | -0.03 | 0.05 | 0.05 |
| IM Cannabis Corp. (IMCC)vs › | $1.14M | N/A | -76.17 | -936.34 | -837.30 |
Trailing EPS (TTM)
$-1.86
Forward EPS (Est.)
$-1.23
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.65 |
| 2024-12-31 | -4.83 |
| 2023-12-31 | -34.01 |
| 2022-12-31 | -31.15 |
| 2021-12-31 | -37.35 |
| 2020-12-31 | -35.68 |
| 2019-12-31 | -66.97 |
| 2018-12-31 | -3173.58 |
| 2017-12-31 | -6480.00 |
| 2016-12-31 | -24840.00 |
| 2015-12-31 | -17640.00 |
| 2014-12-31 | -10800.00 |
| 2013-10-31 | 0.00 |
| 2012-10-31 | -49.11 |
| 2011-10-31 | -0.01 |
| 2010-10-31 | 0.00 |
| 2009-10-31 | 0.00 |
| 2008-10-31 | 0.00 |
